<DOC>
	<DOCNO>NCT01855217</DOCNO>
	<brief_summary>Should dose sugammadex morbid obese patient calculate real body weight ideal body weight ? To study pharmacodynamics sugammadex morbidly obese patient compare 1 mg/kg IBW versus 1 mg/kg TBW versus placebo .</brief_summary>
	<brief_title>Pilot Study Pharmacodynamics Sugammadex Morbidly Obese Patients : Reversal Deep Neuromuscular Blockade</brief_title>
	<detailed_description>Background study : Morbidly obese patient select elective bariatric surgery major anesthetic concern . The risk include difficult airway , difficult mask ventilation , hypoxemia , pre-existent restrictive obstructive lung disease residual anesthetic postoperatively due body habitus . In research investigator focus reversal neuromuscular blockade give patient full muscle strength . Sugammadex A-cyclodextrin design encapsulate rocuronium bromide , frequently use non-depolarizing neuromuscular blocking agent . Sugammadex provide rapid reversal neuromuscular blockade encapsulation . Based available literature , conclude limited information available use sugammadex morbidly obese patient . While degree obesity varies within available study , general , study patient less obese compare population currently undergo bariatric surgery . The pharmaceutical company produce sugammadex state dose base total body weight ( TBW ) adult , regardless presence obesity . However , rocuronium bromide morbidly obese patient dose ideal body weight ( IBW ) . Therefore , investigator hypothesize sugammadex dose base ideal body weight instead total body weight morbidly obese patient . This also relevant economic perspective since cost sugammadex high . Objective study : To study pharmacodynamics sugammadex morbidly obese patient compare 1 mg/kg IBW versus 1 mg/kg TBW versus placebo Study design : This double-blind randomized , placebo control study perform morbidly obese patient BMI &gt; 40 kg/m2 undergo bariatric surgery . Patients undergo bariatric surgery approach ask participate . Before induction anesthesia , neuromuscular train-of-four ( NMT ) ( type M-NMT-00=00 , Datex Engstrom ) apply ulnar nerve use surface electrode . By place two electrode nervus ulnaris give four pulse 0,2 ms duration deliver frequency 2 Hz every 15 second give muscle twitch . With Train-of-four ( TOF ) investigator measure neuromuscular response adductor pollicis muscle calculate neuromuscular blockade time ( TOF percentage ) . The TOF percentage measure induction anesthesia end surgery . According standardized anesthesia protocol , propofol ( 2.5 mg kg-1 ) fentanyl 250microgram give induction anesthesia , upon NMT calibrate resultant force contraction adductor pollicis muscle record . This follow rocuronium 0,6 mg/kg base IBW TOF ratio come 0 % , tracheal intubation take place mechanical ventilation initiate attending anesthesiologist . Patients receive either sugammadex 1 mg/kg base ideal body weight ( IBW ) 1mg/kg base total body weight ( TBW ) placebo 0,9 % NaCl bolus injection double blind fashion . During surgery , attend blind anesthesiologist allow give additional bolus 10 mg atracurium whenever neuromuscular block inadequate opinion TOF ratio exceed 50 % . Atracurium aminosteroidal neuromuscular blocking agent still use patient within unlimited hour use sugammadex , encapsulate sugammadex . Until two hour sugammadex dose patient observe usual manner PACU . Study population : 25 morbidly obese patient Body Mass Index &gt; 40 kg/m2 undergo bariatric surgery include ( laparoscopic gastric banding , -bypass surgery sleeve-gastrectomy ) Inclusion criterion : - Body Mass Index &gt; 40 kg/m2 - 18-65 year old - American Society Anaesthesiologists ( ASA ) physical status II III Exclusion criterion : - Renal insufficiency identify GFR &lt; 60 ml/min/1.73m2 - Use sevoflurane since enhance neuromuscular blockade - Previous succinylcholine use last 24 hour - Use medication enhance neuromuscular blockade aminoglycoside- polypeptide-antibiotics , lincosamide , acylamino-penicilline-antibiotics , tetracycline , high dose metronidazol , M.A.O.-inhibitors , kinidine , magnesium , calcium channel blocker , lithium . - Use medication decrease neuromuscular blockade neostigmine , pyridostigmine , aminopyridinederivates , chronic use corticosteroid , phenytoïne carbamazepine , noradrenaline , azathioprine , theofylline , calciumchloride , kaliumchloride . - hypersensitivity ( allergic ) sugammadex preservative . - Known ejection fraction le 35 % - Liver failure ( &gt; 3 time upper limit normal value ) - Pregnancy breastfeed Intervention : After intubation patient either sugammadex placebo give double blind fashion . Placebo sugammadex 1 mg/kg base IBW 1 mg/kg base TBW give TOF measure every 15 second ratio 50 % achieve . Primary study parameters/outcome study : • Time TOF 50 % Secondary study parameters/outcome study : • Time TOF 5 % 25 % • Time course TOF • Relation TOF % covariates ( TBW , IBW , age , gender etc ) • Quality surgical condition muscle relaxation point view . Nature extent burden risk associate participation , benefit group relatedness : ugammadex drug approve use Europe since 2008 . Safety data indicate sugammadex well tolerate license dose 16 mg/kg . The investigator give 1 mg/kg base ideal total body weight . The use sugammadex induction anesthesia dose may lead insufficient neuromuscular blockade ; use sugammadex , either 1 mg/kg base IBW TBW neuromuscular blockade shorten 7-22 minute 5-15 minute respectively . For placebo group show 0,6 mg/kg rocuronium base ideal body weight give neuromuscular blockade TOF 50 % 20-40 minute . As TOF continuously measure , attend anaesthesiologist monitor neuromuscular blockade use TOF and/or standard criterion consider time administer atracurium increase neuromuscular blockade surgery . The perioperative use TOF monitor consider standard practice</detailed_description>
	<criteria>must Body Mass Index &gt; 40 kg/m2 must 1865 year old must American Society Anesthesiologists ( ASA ) physical status II III Must Renal insufficiency identify GFR &lt; 60 ml/min/1.73m2 Sevoflurane must use since enhance neuromuscular blockade No previous succinylcholine must use last 24 hour No use medication enhance neuromuscular blockade aminoglycoside polypeptideantibiotics , lincosamide , acylaminopenicillinantibiotics , tetracycline , high dose metronidazol , M.A.O.inhibitors , kinidine , magnesium , calcium channel blocker , lithium . No use medication decrease neuromuscular blockade neostigmine , edrofonium , pyridostigmine , aminopyridine derivates , chronic use corticosteroid , phenytoïne carbamazepine , noradrenaline , azathioprine , theophylline , calcium chloride , kaliumchloride . hypersensitivity ( allergic ) sugammadex preservative . ejection fraction le 35 % Liver failure Pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>morbid</keyword>
	<keyword>obesity</keyword>
	<keyword>sugammadex</keyword>
	<keyword>pharmacodynamics</keyword>
</DOC>